BRAF and colorectal carcinoma: This Amsterdam Colorectal Liver Met Registry (AmCORE) based study aimed to assess primary tumor sidedness of CRC, RAS and BRAF mutations and MSI status as prognostic factors predicting complications, survival outcomes and local tumor progression (LTP) following surgery and thermal ablation in patients with CRLM.